Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.
about
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@en
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@nl
type
label
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@en
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@nl
prefLabel
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@en
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@nl
P2093
P2860
P50
P356
P1476
Early Biomarkers from Conventi ...... Recurrent High-Grade Gliomas.
@en
P2093
A A Kanner
A Talianski
C Hoffmann
D T Blumenthal
D Yekutieli
F Bokstein
P2860
P304
P356
10.3174/AJNR.A4866
P50
P577
2016-07-07T00:00:00Z